Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Journal of Lower Genital Tract Disease|December 21, 2020
Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening TrialHui Du, Xianzhi Duan, Yan Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 18, 2022
Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in ChinaLe Dang, Linghua Kong, Yuqian Zhao, et al.
Microbiology Spectrum|August 10, 2022
Genome of Pythium myriotylum Uncovers an Extensive Arsenal of Virulence-Related Genes among the Broad-Host-Range Necrotrophic Pythium Plant PathogensPaul Daly, Dongmei Zhou, Danyu Shen, et al.
International Journal of Cancer|December 13, 2024
The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort studyQi Chen, Xingmei Yao, Jiali Quan, et al.
Photodiagnosis and Photodynamic Therapy|July 5, 2022
Chinese expert consensus on the clinical applications of aminolevulinic acid-based photodynamic therapy in female lower genital tract diseases (2022)Lihua Qiu, Jingran Li, Fei Chen, et al.
JAMA Oncology|December 30, 2020
Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical TrialJunji Zhang, Yuqian Zhao, Yi Dai, et al.
The Lancet Regional Health. Western Pacific|September 16, 2021
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort studyXingmei Yao, Wen Chen, Chao Zhao, et al.
The Lancet Regional Health. Western Pacific|September 2, 2025
Long-term efficacy and immunopersistence of an Escherichia coli-produced HPV-16/18 bivalent vaccine: an observational extension study following a randomised, double-blind Phase III clinical trial cohortFanghui Zhao, Qi Chen, Chao Zhao, et al.
Pageof 21